170 related articles for article (PubMed ID: 20137940)
21. The p95-100 kDa ligand of the T cell-specific adaptor (TSAd) protein Src-homology-2 (SH2) domain implicated in TSAd nuclear import is p97 Valosin-containing protein (VCP).
Marti F; King PD
Immunol Lett; 2005 Mar; 97(2):235-43. PubMed ID: 15752563
[TBL] [Abstract][Full Text] [Related]
22. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein.
He J; Zhu Q; Wani G; Wani AA
Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256
[TBL] [Abstract][Full Text] [Related]
23. Interaction between Smad1 and p97/VCP in rat testis and epididymis during the postnatal development.
Cayli S; Erdemir F; Ocakli S; Ungor B; Kesici H; Yener T; Aslan H
Reprod Sci; 2012 Feb; 19(2):190-201. PubMed ID: 22051847
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K
Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643
[TBL] [Abstract][Full Text] [Related]
25. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
26. Central pore residues mediate the p97/VCP activity required for ERAD.
DeLaBarre B; Christianson JC; Kopito RR; Brunger AT
Mol Cell; 2006 May; 22(4):451-62. PubMed ID: 16713576
[TBL] [Abstract][Full Text] [Related]
27. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
[TBL] [Abstract][Full Text] [Related]
28. UBXD1 is a VCP-interacting protein that is involved in ER-associated degradation.
Nagahama M; Ohnishi M; Kawate Y; Matsui T; Miyake H; Yuasa K; Tani K; Tagaya M; Tsuji A
Biochem Biophys Res Commun; 2009 May; 382(2):303-8. PubMed ID: 19275885
[TBL] [Abstract][Full Text] [Related]
29. Ubxd1 is a novel co-factor of the human p97 ATPase.
Madsen L; Andersen KM; Prag S; Moos T; Semple CA; Seeger M; Hartmann-Petersen R
Int J Biochem Cell Biol; 2008; 40(12):2927-42. PubMed ID: 18656546
[TBL] [Abstract][Full Text] [Related]
30. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Monden M; Yamamoto S; Iuchi K; Aozasa K
Ann Surg Oncol; 2004 Jul; 11(7):697-704. PubMed ID: 15231524
[TBL] [Abstract][Full Text] [Related]
31. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
32. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
33. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of valosin-containing protein (VCP/p97) in untransformed osteoblast-like cells.
Behnam K; Murray SS; Brochmann EJ
J Orthop Res; 2005 May; 23(3):618-24. PubMed ID: 15885483
[TBL] [Abstract][Full Text] [Related]
35. Dendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and Progression.
Walworth K; Bodas M; Campbell RJ; Swanson D; Sharma A; Vij N
PLoS One; 2016; 11(7):e0158507. PubMed ID: 27434122
[TBL] [Abstract][Full Text] [Related]
36. Nucleotide dependent motion and mechanism of action of p97/VCP.
DeLaBarre B; Brunger AT
J Mol Biol; 2005 Mar; 347(2):437-52. PubMed ID: 15740751
[TBL] [Abstract][Full Text] [Related]
37. Valosin-containing protein/p97 interacts with sperm-activating and sperm-attracting factor (SAAF) in the ascidian egg and modulates sperm-attracting activity.
Kondoh E; Konno A; Inaba K; Oishi T; Murata M; Yoshida M
Dev Growth Differ; 2008 Oct; 50(8):665-73. PubMed ID: 18826472
[TBL] [Abstract][Full Text] [Related]
38. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in p97/VCP/Cdc48 cellular functions.
Yamanaka K; Sasagawa Y; Ogura T
Biochim Biophys Acta; 2012 Jan; 1823(1):130-7. PubMed ID: 21781992
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
Gududuru V; Hurh E; Dalton JT; Miller DD
Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
